Atos - comment

The break-up of Atos still remains an option despite management’s aim of achieving a restructuring of Atos as a whole.  Apart from the French state’s approach for a

Read More
Tomás MannionATOS
Atos - comment

The headlines are dominated by a non-binding letter of intent from the French state to acquire 100% of a subset of BDS business for c. €700-1,000m subject to

Read More
Tomás MannionATOS
Oriflame - Two Years

Please find our updated analysis of Oriflame here

It’s finally happening. Membership is beginning to turn around and even a little faster than we imagined. But that’s the good news - all of it. The turnaround is effectively too

Read More
Wolfgang FelixORIFLAME
Cerba - comment

The company reported its Q4 2023 results yesterday well below even our estimates and our initial view is that Cerba is clearly “testing” the patience of investors as it was another weak quarter. Q4 2023 revenues were down 17% at EUR 482 million vs

Read More
Saahil DeyCERBA